The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hallervorden-Spatz Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hallervorden-Spatz Syndrome


High impact information on Hallervorden-Spatz Syndrome


Chemical compound and disease context of Hallervorden-Spatz Syndrome


Gene context of Hallervorden-Spatz Syndrome


  1. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Wisniewski, K., Jervis, G.A., Moretz, R.C., Wisniewski, H.M. Ann. Neurol. (1979) [Pubmed]
  2. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K., Takahashi, H., Lee, V.M., Trojanowski, J.Q., Mann, D., Iwatsubo, T. J. Biol. Chem. (2002) [Pubmed]
  3. Rare causes of hereditary iron overload. Ponka, P. Semin. Hematol. (2002) [Pubmed]
  4. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Albright, A.L., Barry, M.J., Fasick, P., Barron, W., Shultz, B. Neurosurgery (1996) [Pubmed]
  5. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Zhou, B., Westaway, S.K., Levinson, B., Johnson, M.A., Gitschier, J., Hayflick, S.J. Nat. Genet. (2001) [Pubmed]
  6. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Perry, T.L., Norman, M.G., Yong, V.W., Whiting, S., Crichton, J.U., Hansen, S., Kish, S.J. Ann. Neurol. (1985) [Pubmed]
  7. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Eidelberg, D., Sotrel, A., Joachim, C., Selkoe, D., Forman, A., Pendlebury, W.W., Perl, D.P. Brain (1987) [Pubmed]
  8. A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect. Rump, P., Lemmink, H.H., Verschuuren-Bemelmans, C.C., Grootscholten, P.M., Fock, J.M., Hayflick, S.J., Westaway, S.K., Vos, Y.J., van Essen, A.J. Neurogenetics (2005) [Pubmed]
  9. Myopathic involvement in two cases of Hallervorden-Spatz disease. Malandrini, A., Bonuccelli, U., Parrotta, E., Ceravolo, R., Berti, G., Guazzi, G.C. Brain Dev. (1995) [Pubmed]
  10. Cervical myelopathy in an adolescent with Hallervorden-Spatz disease. Fung, G.P., Chan, K.Y. Pediatric neurology. (2003) [Pubmed]
  11. Rehabilitation of patients with Hallervorden-Spatz syndrome. Seibel, M.O., Date, E.S., Zeiner, H., Schwartz, M. Archives of physical medicine and rehabilitation. (1993) [Pubmed]
  12. Progressive ataxia in Swedish children: a re-evaluation study. Ylitalo, V., Hagberg, B.A. Acta neurologica Scandinavica. (1994) [Pubmed]
  13. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. Kyriagis, M., Grattan-Smith, P., Scheinberg, A., Teo, C., Nakaji, N., Waugh, M. Journal of paediatrics and child health. (2004) [Pubmed]
  14. Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome). Gordon, N. Eur. J. Paediatr. Neurol. (2002) [Pubmed]
  15. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Ching, K.H., Westaway, S.K., Gitschier, J., Higgins, J.J., Hayflick, S.J. Neurology (2002) [Pubmed]
  16. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. Case report. Umemura, A., Jaggi, J.L., Dolinskas, C.A., Stern, M.B., Baltuch, G.H. J. Neurosurg. (2004) [Pubmed]
  17. Optic atrophy as the presenting sign in Hallervorden-Spatz syndrome. Casteels, I., Spileers, W., Swinnen, T., Demaerel, P., Silberstein, J., Casaer, P., Missotten, L. Neuropediatrics. (1994) [Pubmed]
  18. Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration. Johnson, M.A., Kuo, Y.M., Westaway, S.K., Parker, S.M., Ching, K.H., Gitschier, J., Hayflick, S.J. Ann. N. Y. Acad. Sci. (2004) [Pubmed]
WikiGenes - Universities